Abiopharma

Celularity Announces Filing of Form 10-Q Quarterly Reports for the First Quarter and the Second Quarter 2025, Confirmation of Nasdaq Listing Rule 5250(c)(1) Compliance

Toloue Masoud 🔴 sold 254 shares of Quanterix Corp (QTRX) at $4.55 Transaction Date: Aug 31, 2025 | Filing ID: 006066

New Form 144 - Premier, Inc. Filed: 2025-09-03 AccNo: 0001959173-25-005726 Size: 4 KB

New Form 144 - Vicarious Surgical Inc. Filed: 2025-09-03 AccNo: 0001969223-25-000711 Size: 6 KB

New Form 144 - Vicarious Surgical Inc. Filed: 2025-09-03 AccNo: 0001969223-25-000712 Size: 6 KB

Investis Notification - Smith+Nephew PLC

New Form 6-K - Zentek Ltd. Filed: 2025-09-03 AccNo: 0001062993-25-015217 Size: 32 KB

New Form 8-K - Gryphon Digital Mining, Inc. Filed: 2025-09-03 AccNo: 0001213900-25-083740 Size: 624 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

Ernexa Therapeutics Announces Presentation At The H.C. Wainwright 27th Annual Global Investment Conference

New Form 424B5 - Gryphon Digital Mining, Inc. Filed: 2025-09-03 AccNo: 0001213900-25-083737 Size: 352 KB

New Form 6-K - PORTAGE BIOTECH INC. Filed: 2025-09-03 AccNo: 0001171843-25-005698 Size: 5 MB

New Form 6-K - ImmunoPrecise Antibodies Ltd. Filed: 2025-09-03 AccNo: 0000950170-25-112677 Size: 53 KB

CNS Pharmaceuticals - New Press Release

Incyte Launches HS TRUTHS to Spotlight the True Lived Experience of Hidradenitis Suppurativa

Illumina, Inc. - Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development